ClinicalTrials.Veeva

Menu

Normal Saline Versus Heparin Intermittent Flushing for the Prevention of Occlusion in Port-a-Cath

Chang Gung Medical Foundation logo

Chang Gung Medical Foundation

Status

Not yet enrolling

Conditions

Port-a-cath Occlusion
Normal Saline
Heparin Lock

Treatments

Drug: Normal Saline Flush 20 ml
Drug: Heparin Flush (1000 USP, 10ml)
Drug: Normal Saline Flush 10 ml

Study type

Interventional

Funder types

Other

Identifiers

NCT05707936
CMRPVVM0141

Details and patient eligibility

About

Purpose:

An evidence implementation of a randomized controlled trial for whether there is the difference in intermittent flushing 0.9% normal saline and heparin? Design: a single-blind randomized controlled trial

Method:

This study is based on the 5A (Ask, Acquire, Appraise, Apply, Audit) of evidence health care step, and design randomized controlled trial for evidence implementation.

We will include inpatients over 20 years-old adults in New Taipei City TuCheng Hospital, Taiwan, who need administration medicine by port-a-catcher. The sample size is 192 according to G-power software. Random allocation software has using for block randomization, would assign to group A: flushing with 0.9% normal saline 10ml, group B: flushing with 0.9% normal saline 20ml, and group C: flushing with heparin 100 USP/ml. SPSS 20.0 software for statistical analysis, mean or standard deviation, one- way ANOVA would use.

Enrollment

192 estimated patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Non-pediatric inpatients over 20 years of age with PAC placed for any disease and who need medication during hospitalization.

Exclusion criteria

History of PAC obstruction, continuous high volume drip via PAC, taking anticoagulant or antiplatelet agents, abnormal blood coagulation, pregnancy or contraceptive use, specified flushing solution by case

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Single Blind

192 participants in 3 patient groups

Normal saline 20 ml
Experimental group
Treatment:
Drug: Normal Saline Flush 20 ml
Normal saline 10 ml
Experimental group
Treatment:
Drug: Normal Saline Flush 10 ml
usual care (heparin)
Active Comparator group
Treatment:
Drug: Heparin Flush (1000 USP, 10ml)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems